Group 1 - The stock price of Xianheng International is reported at 15.05 yuan, down 1.18% from the previous trading day, with a trading volume of 31,660 hands and a transaction amount of 0.48 billion yuan as of August 7, 2025 [1] - Xianheng International is primarily engaged in the research, development, production, and sales of instruments and related products, which are widely used in industries such as electricity, petroleum, chemicals, and metallurgy [1] - In the first quarter of 2025, the company achieved operating revenue of 640 million yuan and a net profit attributable to shareholders of 21.57 million yuan [1] Group 2 - On August 7, the company announced that its shareholder, Goldman Sachs Asia Strategic, holding 5.6063% of shares, plans to reduce its holdings by up to 12.3 million shares, accounting for 3% of the total share capital, starting from August 30, 2025 [1] - The reduction will occur through centralized bidding and block trading, with a maximum of 4.1 million shares to be sold via centralized bidding and 8.2 million shares through block trading [1] - The reason for the reduction is stated as the shareholder's own funding needs [1]

Mergers and Acquisitions - Tengjing Technology has decided to terminate the acquisition of 100% shares of Xunke Communication due to changes in market conditions and difficulties in reaching an agreement on the transaction plan [1] Earnings Disclosure - Ganli Pharmaceutical reported a revenue of 2.067 billion yuan for the first half of 2025, representing a year-on-year increase of 57.18%, and a net profit of 604 million yuan, up 101.96% year-on-year [2] - Shangwei New Materials announced a revenue of 784 million yuan for the first half of 2025, a year-on-year increase of 12.50%, but a net profit of 29.90 million yuan, down 32.91% year-on-year [3] - SMIC reported a sales revenue of 2.209 billion USD for the second quarter of 2025, a quarter-on-quarter decrease of 1.7%, with a gross margin of 20.4%, down 2.1 percentage points quarter-on-quarter [4] Shareholding Changes - Babai Co. announced that its major shareholder, Guangzhou Yunmei Industrial Investment Partnership, plans to reduce its holdings by no more than 2% of the company's shares, equivalent to 223.08 million shares [5] - Xianheng International disclosed that its major shareholder, Goldman Sachs Asia, intends to reduce its holdings by no more than 3%, which amounts to 12.30 million shares [6] - Linuo Pharmaceutical Packaging announced that its shareholders plan to reduce their holdings by no more than 3%, totaling 697.87 million shares [7] Risk Events - Fangsheng Pharmaceutical announced that its actual controller, Zhang Qinghua, has been placed under residential surveillance starting from August 6, 2025 [8]

Mergers and Acquisitions - Tengjing Technology has decided to terminate the acquisition of 100% shares of Xunke Communication due to changes in market conditions and difficulties in reaching an agreement on the transaction plan [1] Performance Disclosure - Ganli Pharmaceutical reported a revenue of 2.067 billion yuan for the first half of 2025, representing a year-on-year increase of 57.18%, and a net profit of 604 million yuan, up 101.96% year-on-year [2] - Shunwei New Materials announced a revenue of 784 million yuan for the first half of 2025, a year-on-year increase of 12.50%, but a net profit of 29.90 million yuan, down 32.91% year-on-year [3] - SMIC reported a sales revenue of 2.209 billion USD for the second quarter of 2025, a quarter-on-quarter decrease of 1.7%, with a gross margin of 20.4%, down 2.1 percentage points quarter-on-quarter [4] Shareholding Changes - Babai Co. announced that its major shareholder, Guangzhou Yunmei Industrial Investment Partnership, plans to reduce its holdings by no more than 223.08 million shares, accounting for 2% of the total share capital [5] - Xianheng International disclosed that its major shareholder, Goldman Sachs Asia, intends to reduce its holdings by no more than 12.30 million shares, representing no more than 3% of the total shares [6] - Lino Pharmaceutical Packaging announced that its shareholders plan to reduce their holdings by no more than 697.87 million shares, accounting for 3% of the total share capital [7] Risk Events - Fangsheng Pharmaceutical announced that its actual controller, Zhang Qinghua, has been placed under residential surveillance starting from August 6, 2025 [8]

Core Viewpoint - A total of 19 A-share listed companies have disclosed share reduction plans, with no companies announcing share increases on the same day [1]. Group 1: Share Reduction Details - Weilon Co., Ltd. plans to reduce no more than 0.7664% of its shares by the controlling shareholder's concerted action [2]. - Gongchuang Turf's shareholders plan to reduce no more than 0.80% of the total shares [2]. - Yujing Co., Ltd. will see a reduction of 1.12% of shares by its controlling shareholder and actual controller Yang Yuhong [2]. - Xiangxin Technology's controlling shareholder and actual controller will reduce 801,300 shares [2]. - Hengji Daxin's controlling shareholder Zhuhai Shiyou intends to reduce no more than 3% of the company's shares [2]. - Hengli Hydraulic's shareholder Shennuo Technology plans to reduce no more than 3% of the company's shares [2]. - Cangzhou Mingzhu's shareholder Junyue Rixin 17 plans to reduce no more than 1.00% of the company's shares [2]. - Tongfu Microelectronics' major fund reduced 13.1424 million shares, bringing its holding ratio down to 6.91% [2]. - Xianheng International's shareholder Goldman Sachs Asia Strategic plans to reduce no more than 12.3 million shares, accounting for no more than 3% [2]. - Hongsheng Co., Ltd.'s shareholder Changzhou Zhongke plans to reduce no more than 2.8594% of the company's shares [2]. - Dongfang Guoxin's controlling shareholder reduced 1.63% of the company's shares on August 6 [2]. - Linuo Pharmaceutical's shareholder plans to reduce no more than 3% of the company's shares [2]. - Yinlun Co., Ltd.'s directors and executives plan to reduce no more than 964,000 shares [2]. - Sanwei Xinan's Zhongwang Investment plans to reduce no more than 1% of the company's shares [2]. - Xue Neng Technology's shareholder Shanghang Xingyuan plans to reduce no more than 1.9832% of the company's shares [2]. - Zhongyan Co., Ltd.'s shareholder Wang Xiuyun plans to reduce no more than 1% of the company's shares [2]. - Zhongyou Technology's director Zhang Zhanguan plans to reduce no more than 0.0009% of the company's shares [2]. - Ruifeng Bank's Antu Automobile plans to reduce no more than 1.20% of the company's shares [2]. - Aili Home's directors and senior management plan to reduce no more than 0.108% of the company's shares [2].

Company Overview - Xianheng International closed at 15.05 yuan, down 1.18%, with a rolling PE ratio of 26.21 times and a total market value of 6.176 billion yuan [1] - The company operates in the MRO (Maintenance, Repair, and Operations) sector, focusing on tools, instruments, and related technical services [1] Financial Performance - For Q1 2025, Xianheng International reported revenue of 640 million yuan, a year-on-year increase of 46.04%, and a net profit of 21.5717 million yuan, up 144.43% [1] - The sales gross margin for the latest quarter was 21.46% [1] Shareholder Information - As of March 31, 2025, Xianheng International had 14,219 shareholders, an increase of 328 from the previous count, with an average holding value of 352,800 yuan and an average holding quantity of 27,600 shares [1] Industry Comparison - The average PE ratio for the instrument and meter industry is 87.29 times, with a median of 62.75 times, placing Xianheng International at 24th in the industry ranking [2] - The industry average market value is 5.226 billion yuan, while the median is 4.106 billion yuan [2]

咸亨国际（605056）(605056.SH)发布公告，近日，公司收到高盛亚洲战略发来的《关于股份减持计划 的告知函》，获悉高盛亚洲战略计划以集中竞价及大宗交易方式减持其持有的公司股份合计不超过1230 万股，减持比例不超过公司总股本的3%。 ...

Group 1 - The core point of the article is that Xiamen International (605056.SH) has received a notice from Goldman Sachs Asia Strategy regarding a share reduction plan [1] - Goldman Sachs Asia Strategy plans to reduce its holdings in the company by up to 12.3 million shares, which represents no more than 3% of the company's total share capital [1]

咸亨国际科技股份有限公司 关于持股 5%以上股东减持股份计划公告 本公司董事会、全体董事及相关股东保证本公告内容不存在任何虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 证券代码：605056 证券简称：咸亨国际 公告编号：2025-042 重要内容提示： 大股东持股的基本情况 截至本公告披露日，股东 GOLDMAN SACHS ASIA STRATEGIC PTE. LTD.（以 下简称"高盛亚洲战略"）持有咸亨国际科技股份有限公司（以下简称"公司"） 无限售流通股份 23,006,506 股，占公司总股本的 5.6063%。 减持计划的主要内容 近日，公司收到高盛亚洲战略发来的《关于股份减持计划的告知函》，获悉 高盛亚洲战略计划以集中竞价及大宗交易方式减持其持有的公司股份合计不超 过 12,300,000 股，减持比例不超过公司总股本的 3%。其中：拟通过集中竞价方 式减持公司股份不超过 4,100,000 股（约占公司总股本比例的 1%）；拟通过大宗 交易方式减持公司股份不超过 8,200,000 股（约占公司总股本比例的 2%）。具体 情况如下： 1、通过集中竞价 ...

Core Viewpoint - Goldman Sachs Asia Strategic Plan, a major shareholder of Xianheng International, plans to reduce its stake by up to 12.3 million shares, representing no more than 3% of the company's total share capital, between August 30, 2025, and November 29, 2025, due to personal funding needs [1] Summary by Category - **Share Reduction Details** - The reduction will occur through centralized bidding and block trading methods, with a maximum of 4.1 million shares to be sold via centralized bidding and up to 8.2 million shares through block trading [1] - **Market Pricing** - The selling price will be determined based on the market price at the time of the reduction [1]

Core Viewpoint - Goldman Sachs Asia Strategic plans to reduce its stake in Xianheng International by up to 12.3 million shares, representing a maximum of 3% of the company's total share capital [1] Group 1 - The shareholder, holding 5.6063% of the company, will execute the reduction through centralized bidding and block trading methods [1]